ROBIN HOWARD W sold NKTR

February 18, 2026 · Form 4 insider transaction

ROBIN HOWARD W sold 423 shares of Nektar Therapeutics at $73.00 per share, a transaction worth $30.9K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Disposed (sell-side)
Shares
423
Price
$73.00
Total value
$30.9K
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 18, 2026
Filing dateFebruary 20, 2026
Shares owned after75,489
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Represents the number of shares sold by the reporting person to cover required tax withholding obligations in connection with the vesting of the RSUs held by the reporting person and does not represent a discretionary trade by the reporting person.; This transaction was executed in multiple trades at prices ranging from $72.51 to $74.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.

View the original Form 4 on SEC EDGAR